Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
J Clin Endocrinol Metab (2000) 85(7):240210
They work intracellularly to block the JAK/STAT signaling pathway, effectively intercepting the downstream signaling of multiple pro-inflammatory cytokines that drive RA tofacitinib mono-therapy has been found to be superior to methotrexate in reducing the symptoms and progression of RA
PMID 16783540
Andreoiu and Cheng, 2010)
FDA has released its briefing materials for the meeting, published its current position on the substances under review, updated the meeting schedule, and announced that another peptide-focused PCAC meeting will take place before the end of February 2027
Genetic commonalities between metabolic syndrome and rheumatic diseases through disease interactome modules
US$ 29.26
US$ 25.49
US$ 22.47
US$ 22.81
US$ 20.64
US$ 23.50
US$ 22.98
US$ 23.52
US$ 27.84
US$ 23.15
US$ 25.47
US$ 28.74
US$ 28.85
